• 폴리머
• /
• 제36권2호
• /
• pp.216-222
• /
• 2012

콘크리트 제조 시 잉여수의 지연 흡수를 위하여 가교된 crosslinked poly(styrene-$alt$-maleic anhydride)(PSMA)가 core이고, PSMA가 shell인 마이크로캡슐 흡수제를 침전중합법으로 제조하였다. Shell의 두께를 조절하기 위하여 (core 단량체의 질량)/(shell 단량체의 질량) 비가 1/1, 1/2 및 1/3이 되도록 하여 cPSMA-PSMA를 중합하였다. FTIR spectrometer를 사용하여 시멘트 포화 수용액 내에서 PSMA가 가수 분해 반응이 일어남을 확인하였다. TEM 분석으로 core/shell 단량체 비가 1/2(cPSMA #3)일 때 마이크로캡슐 구조를 잘 형성하는 것을 관찰하였고, 1/1(cPSMA #2)과 1/3(cPSMA #4)은 불완전한 마이크로캡슐 구조임을 관찰하였다. 시멘트 포화 수용액에서 cPSMA #3의 팽윤비는 초기 20분까지 증가한 후 2시간까지는 감소하였으며, 그 후 24시간까지는 다시 증가하였다. 제조된 cPSMA #3을 시멘트 페이스트에 첨가한 후 시간에 따른 점도 측정 결과 1시간까지는 거의 변화가 없었지만, 그 후 급격한 점도 증가가 일어났다. Core로만 구성된 cPSMA #1을 0.5 wt% 첨가한 시멘트 모르타르의 압축강도는 무첨가 시멘트 모르타르에 비해 약 5% 높게 나타났으며, cPSMA #3을 첨가한 모르타르는 약 7% 증가로 가장 높게 나타났다.

• 대한화학회지
• /
• 제36권1호
• /
• pp.100-106
• /
• 1992

스티렌-말레산(PSMA), 스티렌말레산 무수물(PSMAn), 및 스티렌-말레산의 $Eu^{3+}$ 염(PSMA-Eu)의 형광특성을 tetrahydrofuran 용액에서 연구하였다. 스티렌의 몰%가 75%인 PSMA와 PSMA-Eu은 들뜬 이합체의 결합에너지가 50%나 67%에 비해 크게 나타났다. 들뜬이합체-단위체 형광세기의 비로부터 스티렌 단위체의 농도가 $8.0{\times}10^{-3}M$까지도 분자내 들뜬이합체의 특성을 보였다. 들뜬이합체의 형성메카니즘을 설명하는 기존의 세 가지 모형은 이들 중합체에 대해서는 잘 맞지 않는 듯하다. benzylacetate, mesitylene 및 염소가 치환된 용매들이 들뜬이합체의 형광에 주는 영향을 을 조사하여 그 결과를 몰부피로 해석해 보았다.

• 공업화학
• /
• 제29권3호
• /
• pp.330-335
• /
• 2018

서로 다른 중합 메카니즘(산화 커플링 중합 및 라디칼 중합)을 가지는 둘 이상의 단량체를 동시에 공-증발 기상 중합(SC-VPP)을 하여 유기-유기 전도성 복합 박막을 제조하는 새로운 접근법을 보고한다. 본 연구에서는 SC-VPP 공정을 통해 poly(3,4-ethylenedioxythiophene)(PEDOT)와 poly(styrene-co-maleic anhydride)(PSMA)로 구성된 PEDOT-PSMA 복합 박막을 제조하였다. 유기-유기 전도성 복합체 박막의 제조는 FT-IR 및 $1^H-NMR$ 분석을 통해 확인되었다. 전자주사현미경을 통한 표면 형태학 분석으로 PEDOT-PSMA 박막이 PEDOT 박막보다 좀 더 거친 표면을 보였다. 이것은 소수성 특성을 가지는 PEDOT과 친수성 특성기를 가지는 PSMA와의 좋지 않은 상용성 때문이라고 생각된다. 따라서 PEDOT-PSMA는 PEDOT보다 낮은 전기 전도도를 나타내었지만 약염기인 2-ethyl-4-methyl imidazole을 첨가하면 크게 개선되었다. PEDOT-PSMA의 접촉각은 PEDOT의 경우 $62^{\circ}$에 비해 약 $50^{\circ}$로 친수성이 증가하였고, 이는, PSMA가 가지는 카르보닐기에 의한 것이라 판단된다. 제안된 SC-VPP 기반 유기-유기 하이브리드 박막 제조 경로를 통하여 다양한 고분자 전도성 박막의 표면 특성(친수특성, 기계적 강도, 광학특성 및 표면 거칠기) 등을 제어할 수 있다고 판단한다.

• 대한방사성의약품학회지
• /
• 제4권2호
• /
• pp.65-72
• /
• 2018

Prostate specific membrane antigen (PSMA) is a cell surface membrane protein, which is overexpressed in most prostate cancer. Recently, PET imaging with $[^{68}Ga]$PSMA-HBED-CC has been widely used for the diagnosis of recurrent prostate cancer and the studies on the diagnostic potential of $^{64}Cu$-labeled PSMA ligands reported actively. In this study, we monitored with biological evaluation in vivo and PET imaging of $^{64}Cu$-labeled PSMA ligand ($[^{64}Cu]$PSMA-617). The radiolabelling efficiency and stability of $[^{64}Cu]$PSMA-617 were confirmed by radio-thin layer chromatography. The radiolabeling efficiency of $[^{64}Cu]$PSMA-617 showed over 95%, and stabilities of intact remained over 98% in both human and mouse serum for 48 h. In normal male mice, in vivo uptake of $[^{64}Cu]$PSMA-617 in several organs was measured at 2, 4, 6, 24, 48 h after injection. Rapid blood clearance was observed for $[^{64}Cu]$PSMA-617. The high uptake was observed in the lung, liver, intestines and kidneys at 2 h postinjection, but was low in the other organs (1-2 %ID/g) at 4 h. The dynamic PET/CT images of 22RV1 tumor-bearing nude mice were acquired during 60 min and additionally acquired 24 h and 48 h after injection. In dynamic PET images, $[^{64}Cu]$PSMA-617 uptake ratio in tumors versus muscle was increased as time elaplsed until 60 minutes and remained in tumors at 48 h. In these results, the PET/CT imaging using $[^{64}Cu]$PSMA-617 in prostate cancer is expected to be useful for the diagnosis and treatment of prostate cancer patients.

• 대한방사성의약품학회지
• /
• 제9권1호
• /
• pp.23-33
• /
• 2023

Prostate cancer ranks as the world's second most frequently diagnosed cancer among men, and is responsible for the fifth highest number of cancer-related deaths in this population. The development of effective diagnostic and therapeutic approaches for prostate cancer remains a major challenge in the field of oncology. Over the past few years, the prostate-specific membrane antigen (PSMA) has raised as a hopeful tracer for the diagnosis and treatment of prostate cancer.Various radioisotopes, such as ¹³¹I, ^99mTc, ⁶⁸Ga, and ¹⁷⁷Lu, have been used to label PSMA analogues, with varying degrees of success. Among these, ⁶⁸Ga-PSMA-11 and ¹⁷⁷Lu-PSMA-617 have emerged as the most promising radioligands for clinical use. Recently, researchers have been exploring the use of other radioisotopes, such as ²¹¹At, ⁸⁹Zr, ^64/67Cu, and ^203/212Pb, for the labeling of PSMA-targeted radioligands. These radioisotopes have unique properties that may offer advantages over existing radioligands, such as longer half-lives, higher specific activities, and different emission profiles. Efforts are currently underway to develop these radiopharmaceuticals and make them more widely available for clinical use. These exciting developments highlight the potential of PSMA-targeted radioligands for the diagnosis and treatment of prostate cancer, and provided significant implications for the management of this disease in the future. The current study aims to provide a comprehensive summary of the latest research and clinical applications of radiolabeled PSMA inhibitors for diagnoses and therapy of prostate cancer, emphasizing the exciting developments in the field and their potential impact on clinical practice.

• Korean Journal of Radiology
• /
• 제24권6호
• /
• pp.574-589
• /
• 2023

Radiopharmaceuticals targeting prostate-specific membrane antigens (PSMA) are essential for the diagnosis, evaluation, and treatment of prostate cancer (PCa), particularly metastatic castration-resistant PCa, for which conventional treatment is ineffective. These molecular probes include [⁶⁸Ga]PSMA, [¹⁸F]PSMA, [Al¹⁸F]PSMA, [^99mTc]PSMA, and [⁸⁹Zr]PSMA, which are widely used for diagnosis, and [¹⁷⁷Lu]PSMA and [²²⁵Ac]PSMA, which are used for treatment. There are also new types of radiopharmaceuticals. Due to the differentiation and heterogeneity of tumor cells, a subtype of PCa with an extremely poor prognosis, referred to as neuroendocrine prostate cancer (NEPC), has emerged, and its diagnosis and treatment present great challenges. To improve the detection rate of NEPC and prolong patient survival, many researchers have investigated the use of relevant radiopharmaceuticals as targeted molecular probes for the detection and treatment of NEPC lesions, including DOTA-TOC and DOTA-TATE for somatostatin receptors, 4A06 for CUB domain-containing protein 1, and FDG. This review focused on the specific molecular targets and various radionuclides that have been developed for PCa in recent years, including those mentioned above and several others, and aimed to provide valuable up-to-date information and research ideas for future studies.

• 한국간호교육학회지
• /
• 제24권4호
• /
• pp.358-366
• /
• 2018

Purpose: This purpose of this study was to identify the level of knowledge and attitude of patient safety and patient safety management activity (PSMA) and identify influencing factors of PSMA in nursing students. Methods: The participants were 210 fourth-year nursing students in C and G city. Data were collected with structured questionnaires from October 10 to November 10, 2017. Descriptive statistics, t-test, one way ANOVA, Pearson's correlation and multiple regression with SPSS 21.0 were used. Results: As a result, the level of knowledge of patient safety was 9.05, attitude of patient safety was 4.07, and PSMA was 4.22. The factors influencing PSMA were knowledge and attitude of patient safety. The regression model explained 77% of PSMA. Conclusion: Based on the results of this study, it is suggested that a systematic education program considering factors influencing the patient safety management activities of nursing students be developed.

• 한국직업건강간호학회지
• /
• 제28권4호
• /
• pp.197-207
• /
• 2019

Purpose: This study aimed to examine the relationship between organizational health (OH), safety climate (SC), the nursing working environment (NWE), and engagement in patient safety management activities (PSMA) among operating room nurses and identify the factors that predict engagement in PSMA. Methods: From August 10th to 25th, 2018, 176 operating room nurses who were working in tertiary and general hospitals responded to a structured questionnaire. Using SPSS/WIN 25.0, the collected data were subjected to independent-samples t-test, one-way analysis of variance, Scheffe?test, and Pearson's correlational and multiple stepwise regression analyses. Results: OH and SC were significantly correlated with engagement in PSMA. The factors that predicted engagement in PSMA were OH, NWE, participation in accreditation, years of work experience, and hospital size; together, they explained 17% of the variance in engagement in PSMA. Conclusion: This study revealed that OH has a significant influence on engagement in PSMA among operating room nurses. Therefore, hospitals should aim to create healthy working environments to promote engagement in PSMA among operating room nurses, actively delegate responsibilities to increase their level of participation in accreditation, and implement strategies that maintain high levels of nurse retention.

• 대한방사성의약품학회지
• /
• 제8권2호
• /
• pp.53-61
• /
• 2022

This study aimed to increase the targeting ability against PSMA in cell therapy using metabolic glycoengineering and biorthogonal chemistry and to visualize cell trafficking using PET imaging. Cellular membranes of THP-1 cells were decorated with azide(-N₃) using Ac₄ManNAz by metabolic glycoengineering. Engineered THP-1 cells were conjugated with DBCO-bearing fluorophore (ADIBO-Cy5.5) for 1 h at different concentrations and analyzed by confocal fluorescence microscopy and flow cytometry. For PSAM ligand conjugation to THP-1 cells, Ac₄ManNAz treated THP-1 cells were incubated with DBCO-PSMA ligand (ADIBO-GUL) at a final concentration with 100 µM for 1 h. To evaluate the effect on cell recognition, PSMA ligand conjugated THP-1 cells(as effectors) were co-cultured with PSMA positive 22RV1 (as target cells) at 3 : 1 a effector-to-target cell (E/T) ratio. The interaction between THP-1 and 22RV1 was monitored by confocal fluorescence microscopy. For preparing the radiolabeled THP-1, the cells were treated at the activity of ~ 740 kBq of [⁸⁹Zr]Zr(oxinate)₄/5 × 10⁶ cells. Radiolabeled cells were analyzed for determination of cell-associated radioactivity by gamma counting and viability using MTS assay. In the cytotoxicity assay, THP-1 cells did not have any cytotoxicity even when the Ac₄ManNAz concentration was 100 µM. In confocal microscopy and flow cytometry, THP-1 cells were efficiently labeled ADIBO-Cy5.5 in a dose-dependent manner, and the dose of 100 µM was the optimal concentration for the following experiments. The clusters of PSMA ligand-conjugated THP-1 cells and 22RV1 cells were identified, indicating cell-cell recognition over the cell surface between two types of cells. Cell radiolabeling efficiency was 54.5 ± 17.8%. THP-1 labeled with 0.09 ± 0.03 Bq/cell showed no significant cytotoxicity compared to unlabeled THP-1 up to 7 days. We successfully demonstrated that Ac₄ManNAz treated cells were efficiently conjugated with ADIBO-GUL for preparing the PSMA-targeting cells, and [⁸⁹Zr]Zr(oxinate)₄ could be used to label cells without toxicity. It suggested that PSMA-ligand conjugated cell therapy could be improved cell targeting and be monitored by PET imaging.

• 대한임상검사과학회지
• /
• 제56권2호
• /
• pp.147-155
• /
• 2024

⁶⁸Ga-PSMA-11은 전립선특이막항원(PSMA)에 결합하는 Glu-urea-Lys 기반 리간드에 ⁶⁸Ga 방사성동위원소를 표지한 PET 제제로, 재발성 전립선암 및 전이의 진단과 치료를 위한 영상화에 널리 사용한다. 그러나 의료기관에서 ⁶⁸Ga-PSMA-11을 제조하고 품질검사 시험 결과가 나올 때까지의 시간은 평균 60분 이상 소요되어, 하루에 사용할 수 있는 ⁶⁸Ge/⁶⁸Ga 제너레이터 용량이 제한된다. 또한 제너레이터의 1,110 MBq (30 mCi)의 명목상 활성을 제공하지만 시간이 지남에 따라 감소하고, 표지 수율이 불규칙적으로 저하된다. 이로 인해 의료기관에서는 추가 조제를 통해 동일한 용출을 유지해야 하며, 이 과정에서 작업자의 피폭 위험이 증가하고, 환자의 대기 시간이 길어지며, 제조 스케줄 조정이 불가피한 임상적 문제가 발생한다. 본 연구는 이러한 문제를 해결하기 위해 ⁶⁸Ga-PSMA-11의 조제 시간을 단축하고 자동합성장치를 최적화하는 것을 목표로 하였다. 자동합성장치를 이용한 합성 절차에서 ⁶⁸Ga과 PSMA-11 전구체의 반응 시간을 단축하고 불순물 제거 세척 단계의 횟수를 조절하여 동일한 품질을 유지하면서도 더 신속하고 경제적인 방법을 시험했다. 그 결과, 최종 합성 시간을 30분에서 20분으로 단축하였고, HEPES 함량, 잔류용매 EtOH 함량, 방사화학적 순도 등의 품질 기준을 만족시켰다. 이는 추가 조제로 인한 작업자의 피폭 문제와 환자의 대기 시간을 줄이고, 제조 스케줄 조정에도 문제가 없는 최적의 절차로 임상에서 적용할 수 있음을 시사한다.